IM Cannabis Corp.
No SEC Form 4 filings for $IMCC in the last 30 days.
See all $IMCC insider activity →IM Cannabis Corp. (IMCC) closed a registered direct offering, selling 655,000 common shares at $2.00 each, raising $1.31M. Proceeds will be used for working capital and potential business opportunities. A related party transaction involved Invest-Pro, a company led by a director of IMCC, purchasing 164,585 shares.
IM Cannabis (IMCC) shares fell 25.85% after announcing a $1.31M share offering and a non-binding deal to acquire 51% of Space Defense Innovations, expanding into defense technology. The acquisition, if completed, would be funded with shares, warrants, and a loan. IM Cannabis operates medical cannabis businesses in Israel and Germany.
IM Cannabis Corp (IMCC) shares dropped 18.6% premarket after announcing a $1.31M share offering at a discount. The company cited financial hardship, with proceeds earmarked for working capital and potential opportunities. The offering may include related parties and is set to close by September 24, 2026.
Over the past 7 days, AlphAI's AI scored 7 news stories mentioning IMCC (IM Cannabis Corp.). Coverage has been balanced: 3 bullish, 1 neutral, and 3 bearish.
Recent IMCC coverage spans corporate actions, earnings and mergers & acquisitions.
Modest capital infusion to support working capital; limited upside for price.
The capital raise dilutes existing shareholders and the pending acquisition adds execution risk, supporting further downside.
The discounted offering dilutes existing shareholders and signals financial distress.
Potential expansion into European tactical UAS market could diversify revenue and increase valuation.
Large intraday price surge likely driven by speculative buying; no fundamental news.
AlphAI scores every news story that mentions IMCC with an AI model for sentiment and relevance, and aggregates insider trades from IM Cannabis Corp.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
IM Cannabis Corp. (IMCC) closed a registered direct offering, selling 655,000 common shares at $2.00 each, raising $1.31M. Proceeds will be used for working capital and potential business opportunities. A related party transaction involved Invest-Pro, a company led by a director of IMCC, purchasing 164,585 shares.
2 min readIM Cannabis (IMCC) shares fell 25.85% after announcing a $1.31M share offering and a non-binding deal to acquire 51% of Space Defense Innovations, expanding into defense technology. The acquisition, if completed, would be funded with shares, warrants, and a loan. IM Cannabis operates medical cannabis businesses in Israel and Germany.
2 min readIM Cannabis Corp (IMCC) shares dropped 18.6% premarket after announcing a $1.31M share offering at a discount. The company cited financial hardship, with proceeds earmarked for working capital and potential opportunities. The offering may include related parties and is set to close by September 24, 2026.
2 min readIM Cannabis Corp. (IMCC) has entered a non-binding agreement to acquire 51% of Space Defense Innovations LLC (SDI), a Polish company operating in the unmanned aerial systems (UAS) sector. The deal involves IMCC common shares, pre-funded warrants, and a seller loan. SDI distributes BlueBird Aero Systems' tactical UAS and hybrid fixed-wing VTOL-UAS platforms in Europe.
2 min readIM Cannabis (IMCC) surged 245% with no clear catalyst, trading between $2.97 and $8.65. XORTX (XRTX) rose 12% on plans for a 2026 FDA application. Silo Pharma (SILO) gained 6.73% after a U.S. patent allowance. Biofrontera (BFRI) increased 5.65% despite no new news, following an FDA approval for Ameluz.
2 min readIM Cannabis Corp. (IMCC) raised US$225,000 through a convertible note financing with an institutional investor. The note bears 8% interest, convertible into common shares at a fixed or market-based price. Proceeds will be used for general corporate purposes. The company also issued warrants for 77,855 shares. IMCC operates in Israel and Germany, with plans to sell its German operations.
1 min readIM Cannabis Corp. (IMCC) plans a 30:1 share consolidation by September 15, 2026, to meet Nasdaq's $1.00 minimum bid price requirement. The company expects 603,922 shares post-consolidation, with trading to resume on August 27, 2026. The move aims to regain compliance with Nasdaq's listing rules.
4 min readIM Cannabis (IMCC) agreed to sell all shares of its subsidiary I.M.C. Holdings Ltd., holding European-focused assets, to Slil.com Holding Ltd. under a definitive share purchase agreement. The deal includes Slil acknowledging prior C$3.0M advances and assuming liabilities up to C$9.4M, with about C$10.0M intercompany debt repaid. Pro forma liabilities fall to C$16.0M from C$30.3M; shareholders’ deficit narrows to C$2.6M. Closing is due by Sept. 30, 2026, subject to conditions.
4 min readIM Cannabis Corp. (Nasdaq: IMCC) reported Q2 2026 and first-half 2026 results. For six months ended June 30, 2026, revenue fell to C$16.3M from C$25.2M, gross profit to C$2.9M from C$6.9M, and net loss to C$6.9M (C$0.85/share). Q2 revenue was C$7.6M, net loss C$4.4M (C$0.47/share). Cash was C$1.6M at June 30, 2026.
4 min readIM Cannabis Corp. (IMCC) furnished an SEC Form 6-K — earnings release. Exhibit 99.1 IM Cannabis Corp. Announces Second Quarter and First Half 2026 Financial Results TORONTO and GLIL YAM, Israel, August 13, 2026 /PRNewswire/ -- IM Cannabis Corp. (" IMC " or the " Company ") (Nasdaq: IMCC), today announced its financial results for the three and six m
2 min read
